Leonteq Securities AG’s INmune Bio INMB Stock Holding History

Leonteq Securities AG’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.08K	Hold	2,500	–	–	﹤0.01%	1111
2026 Q1	$2.83K	Hold	2,500	–	–	﹤0.01%	1152
2025 Q4	$3.9K	Hold	2,500	–	–	﹤0.01%	1276
2025 Q3	$5.17K	Hold	2,500	–	–	﹤0.01%	1162
2025 Q2	$5.78K	Hold	2,500	–	–	﹤0.01%	1122
2025 Q1	$19.5K	Hold	2,500	–	–	﹤0.01%	986
2024 Q4	$11.7K	Hold	2,500	–	–	﹤0.01%	1028
2024 Q3	$13.5K	Buy	2,500 +900	+56%	+$6.4K	﹤0.01%	953
2024 Q2	$14.1K	Hold	1,600	–	–	﹤0.01%	951
2024 Q1	$18.8K	Hold	1,600	–	–	﹤0.01%	935
2023 Q4	$18K	Hold	1,600	–	–	﹤0.01%	948
2023 Q3	$10.9K	Hold	1,600	–	–	﹤0.01%	1000
2023 Q2	$14.5K	Sell	1,600 -1,200	-43%	-$9.64K	﹤0.01%	994
2023 Q1	$18.1K	Hold	2,800	–	–	﹤0.01%	935
2022 Q4	$17.8K	Hold	2,800	–	–	﹤0.01%	982
2022 Q3	$17.4K	Sell	2,800 -1,000	-26%	-$8.78K	﹤0.01%	977
2022 Q2	$33.6K	Buy	3,800 +1,000	+36%	+$7.44K	﹤0.01%	897
2022 Q1	$23.6K	Hold	2,800	–	–	﹤0.01%	985
2021 Q4	$28.6K	Buy	2,800 +1,500	+115%	+$22.2K	﹤0.01%	987
2021 Q3	$25.2K	Buy	+1,300	New	+$25.1K	﹤0.01%	938

Other funds holding INMB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Leonteq Securities AG's INMB Position: Q2 2026 in Review

Leonteq Securities AG held its INmune Bio (INMB) position steady in Q2 2026 at 2,500 shares worth $4.08K. The position accounts for ﹤0.01% of the portfolio, ranked #1111.

Leonteq Securities AG first reported a position in INMB in Q3 2021 and has held it in 20 quarters since. The position peaked at $33.6K in Q2 2022. 83 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

Leonteq Securities AG held 2,500 shares of INmune Bio worth $4.08K as of Q2 2026.
Leonteq Securities AG left its INmune Bio share count unchanged in Q2 2026.
INmune Bio made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1111 holding.
Leonteq Securities AG first reported a position in INmune Bio in Q3 2021 and has held it in 20 quarters since.
Leonteq Securities AG's INmune Bio position peaked at $33.6K in Q2 2022.
83 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.